N6, N6-Dimethyladenosine (Standard)
N6, N6-Dimethyladenosine (Standard) is the analytical standard of N6, N6-Dimethyladenosine. This product is intended for research and analytical applications. N6, N6-Dimethyladenosine, a modified ribonucleoside, is an endogenous A3 adenosine receptor ligand. N6, N6-Dimethyladenosine is an AKT inhibitor with antitumor effects. N6, N6-Dimethyladenosine targets SARS-CoV-2 entry protein ADAM17. N6, N6-Dimethyladenosine robustly inhibits AKT signaling in a variety of non-small cell lung cancer cell lines.
Product Specifications
CAS Number
2620-62-4
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Adenosine Receptor; Akt; Nucleoside Antimetabolite/Analog; Reference Standards; SARS-CoV
Related Pathways
Anti-infection; Cell Cycle/DNA Damage; GPCR/G Protein; Others; PI3K/Akt/mTOR
Field of Research
Cancer; Infection
Purity
99.94
Smiles
O[C@H]1[C@@H](O)[C@H](N2C(N=CN=C3N(C)C)=C3N=C2)O[C@@H]1CO
Molecular Formula
C12H17N5O4
Molecular Weight
295.29
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, sealed storage, away from light and moisture
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Nucleophosmin (Acute Myeloid Leukemia Marker) (NPM1/1902), Biotin conjugate, 0.1mg/mL
